Model ‐based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke
British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-. (Source: British Journal of Clinical Pharmacology)
Source: British Journal of Clinical Pharmacology - July 13, 2018 Category: Drugs & Pharmacology Authors: JinjuGuk , DongwooChae , HankilSon , JoonsangYoo , Ji HoeHeo , KyungsooPark Source Type: research

Proton pump inhibitors and Raynaud's phenomenon: is there a link?
British Journal of Clinical Pharmacology, EarlyView. (Source: British Journal of Clinical Pharmacology)
Source: British Journal of Clinical Pharmacology - July 13, 2018 Category: Drugs & Pharmacology Authors: CharlesKhouri , BrunoRevol , Jean ‐LucCracowski , MatthieuRoustit Source Type: research

Model ‐based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke
British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-. (Source: British Journal of Clinical Pharmacology)
Source: British Journal of Clinical Pharmacology - July 13, 2018 Category: Drugs & Pharmacology Authors: JinjuGuk , DongwooChae , HankilSon , JoonsangYoo , Ji HoeHeo , KyungsooPark Source Type: research

Proton pump inhibitors and Raynaud's phenomenon: is there a link?
British Journal of Clinical Pharmacology, EarlyView. (Source: British Journal of Clinical Pharmacology)
Source: British Journal of Clinical Pharmacology - July 13, 2018 Category: Drugs & Pharmacology Authors: CharlesKhouri , BrunoRevol , Jean ‐LucCracowski , MatthieuRoustit Source Type: research